stockrow
Monday 9 November 2026
Export IVF’s income statement to Excel — free account
INVO Fertility, Inc
IVFINVO Fertility, Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.8 million, up 4.74% from fiscal 2024.
- Revenue
- +16.7%
- EPS
- +100.1%
- Free cash flow
- +35.1%
- Total debt
- −50.7%
Quarter to June 2026, against a year earlier
2.14
0.11
+5.42%
Follow IVF
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
2.13 | 2.47 | 0.81 | 1.51 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(14.53) | (9.30) | 219.30 | (5.90) | |
P/B ratio |
0.99 | 1.22 | 1.15 | 0.00 | |
Price to Tangible BV |
2.92 | 2.65 | 0.00 | 0.00 | |
EV/Sales |
1.72 | 1.90 | 0.63 | 1.62 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(2.71) | (2.55) | (0.62) | (1.47) | |
EV/FCF |
(2.68) | (2.53) | (0.62) | (1.44) | |
Quick Ratio |
0.61 | 0.81 | 0.22 | 0.07 | |
Current Ratio |
0.71 | 0.90 | 0.27 | 0.12 | |
Net Debt/EBITDA |
2.81 | 2.93 | 5.91 | (0.43) | |
Debt/Assets |
1.99% | 2.68% | 3.68% | 5.85% | |
Debt/Equity |
0.03 | 0.04 | 0.10 | 0.19 | |
Asset Turnover |
0.33 | 0.26 | 0.21 | 0.39 | |
Operating CF/Net income |
(1.24) | 0.35 | (0.04) | 0.52 | |
Capex/Depreciation |
(0.13) | 0.00 | (0.01) | 0.10 | |
Interest Coverage |
(7.28) | (8.82) | (3.46) | (11.22) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
87.65% | 107.98% | 114.49% | 121.11% | |
Intangible Assets out of Total Assets |
0.41 | 0.32 | 0.36 | 0.39 | |
Share Based Compensation of Revenue |
1.12% | 3.52% | 8.86% | 27.40% | |
Graham Net Nets |
(0.30) | (0.22) | (1.85) | (1.13) | |
Graham Number |
0.00 | 0.00 | 0.00 | 1,925.87 | |
Earnings Yield |
(582.89%) | (3,758.73%) | (25,777.41%) | (3,859.01%) | |
Free Cash Flow Yield |
(30.11%) | (30.47%) | (127.75%) | (74.14%) | |
Revenue per Share |
1.03 | 1.23 | 4.31 | 20.38 | |
Operating CF per Share |
(0.52) | (1.17) | 0.07 | (20.61) | |
Capex per Share |
(0.01) | 0.00 | (0.03) | (0.09) | |
Free Cash Flow per Share |
(0.53) | (1.17) | 0.04 | (20.70) | |
Cash per Share |
1.77 | 2.99 | 5.66 | 4.13 | |
Shareholders Equity per Share |
7.83 | 9.17 | 19.67 | 67.85 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.83 | 9.17 | 19.67 | 67.85 | |
Free Cash Flow |
(1.12) | (1.92) | 0.01 | (1.78) | |
Working Capital |
(1.92) | (0.62) | (7.57) | (8.11) | |
Capital Expenditures |
(0.02) | — | (0.01) | (0.01) | |
Net Current Asset Value |
(4.74) | (3.90) | (10.23) | (11.85) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.00 | 0.01 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.25 | 0.21 | 0.17 | 0.27 | |
Average Payables |
1.91 | 3.23 | 2.57 | 2.52 | |
Average Inventory |
0.23 | 0.22 | 0.22 | 0.22 | |
Average Assets |
22.58 | 28.20 | 33.15 | 17.93 | |
Average Common Equity |
4.30 | (6.21) | (6.49) | (5.35) |
Columns are period end dates · fundamentals updated 26 Oct 2026